´ëÇѹα¹ ¿¬±¸ÀںеéÀÇ µ¿¹ÝÀÚ°¡ µÇ°Ú½À´Ï´Ù. ´Ù¾çÇÑ ÆéŸÀÌµå ¶óÀ̺귯¸® Á¤º¸¸¦ °øÀ¯µå¸³´Ï´Ù.

ÇÏ´Ü¿¡ »ó¼¼¿µ¿ªº° Ä«Å×°í¸®¸¦ ´­¸£½Ã¸é º¸´Ù ½±°Ô ¿øÇÏ´Â Á¦Ç°À» ãÀ»¼ö ÀÖ½À´Ï´Ù. We will be your companion with our high technology and sufficent Know -how. If press below, You could easily find out several kinds of related informations.


Ä«Å×°í¸® Oligopeptide
CAT.NO
PRODUCT Pro-Leu-Gly-NH2 (PLG)
Size
Price

Product name: Pro-Leu-Gly-NH2 (PLG)

Synonyms: 7-9-Oxytocin, Melanostatin, Melanostatin I (ox), Prolylleucylglycine amide,Oxytocin (7-9),MIF-1,MSH Release-Inhibiting Factor,MSH Release-Inhibiting Hormone,Melanocyte-Stimulating Hormone Release-Inhibiting Factor,

Sequence: Pro-Leu-Gly-NH2

Purity: 95% by HPLC

Format: White powder

Description: L-Prolyl-L-leucylglycinamide (PLG) is a CNS neuropeptide that acts as a modulator of the dopamine receptor. PLG has been shown to enhance the binding of agonists such as N-propylnorapomorphine (NPA) and apomorphine.
MIF-1 has effects on CNS activity, including learning and behavior. MIF-1 shows therapeutic effects in animal models of Parkinson¡¯s disease.

Compound ID: 92910    

 

Usage: For Scientific Research Use Only, Not for Human Use.

 

Reference:

Curr Pharm Des. 2010 Oct; 16(30): 3390–3400.

Pharmacol. 2010 Sep 1, 641(2-3):96-101.

J Med Chem. 2006 Jan 12, 49(1): 307–317.

Mishra RK. Nutr Health. 1984, 3(3):175-87.

÷ºÎÆÄÀÏ

¸Þ´º´Ý±â

°ßÀû¹®ÀÇ

INQUIRY

¾Æ·¡ Ç׸ñ¿¡ ¸Â°Ô Á¤È®È÷ ÀÔ·ÂÇÏ¿© ÁֽʽÿÀ.